✦ LIBER ✦

PND22 Pharmacoeconomic Assessment of Natalizumab in the Treatment of Multiple Sclerosis

✍ Scribed by N.V. Matveev; A.V. Sabanov

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND32 Economic Evaluation of Natalizumab

✍ Reyes, A.; Sánchez-Mejorada, G.; Trejo, W. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND9 THE COST-EFFECTIVENESS OF NATALIZUM

✍ K Meyer; E Chiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PND3 THE BUDGETARY IMPACT OF THE UTILIZA

✍ E Chiao; K Meyer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Pharmacoeconomic Considerations in the T

✍ Jessica Sharac, Dr Paul McCrone, Ramon Sabes-Figuera 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 164 KB

PND25 ECONOMIC EVALUATION OF NATALIZUMAB

✍ C Brennig; E Walter; V Schöllbauer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB